Literature DB >> 26261546

MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.

Luoqiang Lin1, Dan Liu2, Hongyan Liang1, Li Xue1, Changlei Su3, Ming Liu1.   

Abstract

Breast cancer is the most common cancer in women around the world. However, the molecular mechanisms underlying breast cancer pathogenesis are only partially understood. Here, in this study, we found that miR-1228 was up-regulated in breast cancer cell lines and tissues. Ectopic expression of miR-1228 mimics leads to promoted cell growth, invasion and migration. Using bioinfomatic analysis and 3'UTR luciferase reporter assay, we determined SCAI can be directly targeted by miR-1228, which can down-regulate endogenous SCAI protein level. Furthermore, our findings demonstrate that SCAI was down-regulated in breast cancer cell lines and tissues. Rescue experiment demonstrated that miR-1228 promoted cell growth is attenuated by over-expression of MOAP1 and miR-1228 promoted cell invasion and migration can be attenuated by over-expression of SCAI. Taken together, this study provides evidences that miR-1228 serves as an oncogene to promote breast cancer proliferation, invasion and migration, which may become a critical therapeutic target for breast cancer treatment.

Entities:  

Keywords:  Breast cancer; SCAI; cell invasion; cell migration; cell proliferation; miR-1228

Mesh:

Substances:

Year:  2015        PMID: 26261546      PMCID: PMC4525880     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status.

Authors:  Rupninder Sandhu; Jessica Rein; Monica D'Arcy; Jason I Herschkowitz; Katherine A Hoadley; Melissa A Troester
Journal:  Carcinogenesis       Date:  2014-08-14       Impact factor: 4.944

Review 2.  The role of microRNA in resistance to breast cancer therapy.

Authors:  Neil M Robertson; Mehmet V Yigit
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-07-08       Impact factor: 9.957

3.  Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.

Authors:  Xiangrong Chen; Weipeng Hu; Baoyuan Xie; Hongzhi Gao; Chaoyang Xu; Junyan Chen
Journal:  Biochem Biophys Res Commun       Date:  2014-04-29       Impact factor: 3.575

4.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

5.  SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin.

Authors:  Dominique T Brandt; Christian Baarlink; Thomas M Kitzing; Elisabeth Kremmer; Johanna Ivaska; Peter Nollau; Robert Grosse
Journal:  Nat Cell Biol       Date:  2009-04-06       Impact factor: 28.824

Review 6.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

7.  MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.

Authors:  Lu Deng; Li Shang; Shoumin Bai; Ji Chen; Xueyan He; Rachel Martin-Trevino; Shanshan Chen; Xiao-Yan Li; Xiaojie Meng; Bin Yu; Xiaolin Wang; Yajing Liu; Sean P McDermott; Alexa E Ariazi; Christophe Ginestier; Ingrid Ibarra; Jia Ke; Tahra Luther; Shawn G Clouthier; Liang Xu; Ge Shan; Erwei Song; Herui Yao; Gregory J Hannon; Stephen J Weiss; Max S Wicha; Suling Liu
Journal:  Cancer Res       Date:  2014-09-12       Impact factor: 12.701

8.  Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.

Authors:  David L Waning; Khalid S Mohammad; Theresa A Guise
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

9.  MicroRNAs in the Regulation of MMPs and Metastasis.

Authors:  Mohammed Abba; Nitin Patil; Heike Allgayer
Journal:  Cancers (Basel)       Date:  2014-03-25       Impact factor: 6.639

10.  S100A4 overexpression proves to be independent marker for breast cancer progression.

Authors:  Nawfal I Ismail; Gurjeet Kaur; Hasnah Hashim; Mohammed S Hassan
Journal:  Cancer Cell Int       Date:  2008-09-05       Impact factor: 5.722

View more
  15 in total

1.  Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in the TP53 Axis and Carcinogenesis-Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic.

Authors:  Laila Al-Eryani; Sabine Waigel; Ashish Tyagi; Jana Peremarti; Samantha F Jenkins; Chendil Damodaran; J C States
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

2.  Alterations in SCAI Expression during Cell Plasticity, Fibrosis and Cancer.

Authors:  Ákos Gasparics; Gábor Kökény; Attila Fintha; Rita Bencs; Miklós M Mózes; Emese Irma Ágoston; Anna Buday; Zoltán Ivics; Péter Hamar; Balázs Győrffy; László Rosivall; Attila Sebe
Journal:  Pathol Oncol Res       Date:  2017-08-16       Impact factor: 3.201

3.  CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression.

Authors:  Daishi Chen; Wei Ma; Zhaoyang Ke; Fei Xie
Journal:  Cell Cycle       Date:  2018-09-13       Impact factor: 4.534

4.  Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells.

Authors:  Lili Chang; He Gao; Li Wang; Ning Wang; Shumei Zhang; Xiaona Zhou; Huijun Yang
Journal:  Aging (Albany NY)       Date:  2021-04-21       Impact factor: 5.682

5.  Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.

Authors:  Willemijne A M E Schrijver; Paul J van Diest; Cathy B Moelans
Journal:  Oncotarget       Date:  2017-01-10

6.  STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway.

Authors:  Nan Wang; Xianli He; Ru Zhou; Guozhan Jia; Qing Qiao
Journal:  Onco Targets Ther       Date:  2018-06-15       Impact factor: 4.147

Review 7.  Exosomal MiRNAs in Pediatric Cancers.

Authors:  Angela Galardi; Marta Colletti; Virginia Di Paolo; Patrizia Vitullo; Loretta Antonetti; Ida Russo; Angela Di Giannatale
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

8.  Exosomal CircGDI2 Suppresses Oral Squamous Cell Carcinoma Progression Through the Regulation of MiR-424-5p/SCAI Axis.

Authors:  Yu Zhang; Kaiqi Tang; Lizhu Chen; Meng Du; Zhi Qu
Journal:  Cancer Manag Res       Date:  2020-08-20       Impact factor: 3.989

9.  Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.

Authors:  Francesca Conserva; Mariagrazia Barozzino; Francesco Pesce; Chiara Divella; Annarita Oranger; Massimo Papale; Fabio Sallustio; Simona Simone; Luigi Laviola; Francesco Giorgino; Anna Gallone; Paola Pontrelli; Loreto Gesualdo
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

10.  Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals.

Authors:  Devis Pascut; Luisa Cavalletto; Muhammad Yogi Pratama; Silvia Bresolin; Luca Trentin; Giuseppe Basso; Giorgio Bedogni; Claudio Tiribelli; Liliana Chemello
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.